HorsesIMMUNE ONEtm is a pelleted equine supplement containing LARCH ARABINOGALACTAN (AG), a naturally occurring polysaccharide extracted from the Western Larch tree. Due to its broad molecular weight (MW), AG is a strong immune stimulant (modulator) and simultaneously an anti-inflammatory. (Please visit our faq page.) ![]() The AG used in SOURCE ONE supplements contains 2.8% polyphenols including water soluble QUERCETIN. QUERCETIN inhibits the release of histamines and leukotrienes into the bloodstream assisting in the prevention and treatment of allergies and inflammation. AG is 85% soluble fiber with low flatulation potential and has been shown to improve and maintain regularity and overall colon health. LARCH AG has been proven to stimulate the body's increased production of macrophages and natural killer (NK) cells. Numerous university studies have been conducted on the use of AG for humans and animals. University of Montana holds U. S. Patent #5,614,501 on LARCH AG and includes the use of the composition to: The equine supplements IMMUNE ONEtm and SENIOR MOBILITYtm were developed with veterinarians over a two year period of time. During this time the efficacy of the AG was determined, a dose established and a delivery system developed. These two SOURCE ONE NATURALStm equine pelleted supplements contain AG in a natural feed base. This base contains: The use of IMMUNE ONEtm and SENIOR MOBILITYtm arabinogalactan supplements by veterinarians and users over a two year period indicate that they may be of beneficial nutritional support for such conditions as: For more information see the faq page. Please contact us with any questions. We'd love to hear from you. See the order page for current pricing. REFERENCE: U.S. PATENT 35,614,501; JOURNAL OF ALLERGY & CLINICAL IMMUNOLOGY 73:819-823; NUTRITIONAL SCIENCE NEWS, PHYTOCHEMICALS: NUTRIENTS OF THE FUTURE 9/95; PROBIOTICS, HOLM PRESS 1995; JOCHEN HAUER & F. ALFRED ANDERER, CANCER IMMUNOLOGY IMMUNOTHERAPY, SPRINGER-VERLAG 1993; JOURNAL OF NATUROPATHIC MEDICINE, LARCH ARABINOGALACTAN RESEARCH, P. D'ADAMO, N.D.; TSAO D SHI Z WONG A AND KIM YS CANCER RESEARCH 1983, 43:1217-1222. THE STATEMENTS USED HEREIN HAVE NOT BEEN EVALUATED BY THE FDA. THESE PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE OR CONDITION. |
|
top
THE STATEMENTS USED HEREIN HAVE NOT BEEN EVALUATED BY THE FDA. THESE PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE OR CONDITION. photos courtesy Carolyn Schroeder |